New enzyme targets for selective cancer therapies

22 agosto 2014

Compounds that target brain cancer have been recently developed by researchers. The team synthesized a first-of-its-kind inhibitor that prevents the activity of an enzyme called neuraminidase. Although flu viruses use enzymes with the same mechanism as part of the process of infection, human cells use their own forms of the enzyme in many biological processes.